Biopharma Updates: Sumitomo Surges on US Sales While INmune Bio Pushes Cancer Pipeline
Sumitomo Pharma is feeling pretty optimistic about its recently ended fiscal year. Riding a wave of strong North American sales,...
Sumitomo Pharma is feeling pretty optimistic about its recently ended fiscal year. Riding a wave of strong North American sales,...
In the fast-moving US biopharmaceutical sector, Carlsbad-based Palisade Bio, Inc. continues to draw attention with its specialized focus on gastrointestinal...
As the mining industry looks toward 2026, the forecast appears to be a balancing act between surging demand for energy...